| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1041641599 |
| P356 | DOI | 10.1097/01.GIM.0000204468.85308.86 |
| P698 | PubMed publication ID | 16540748 |
| P5875 | ResearchGate publication ID | 7237464 |
| P2093 | author name string | Michael H Lehmann | |
| Stephen M Modell | |||
| P2860 | cites work | Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels | Q44771531 |
| Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland | Q47398470 | ||
| Measures of cardiac repolarization and body position in infants | Q48633445 | ||
| Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome | Q48678936 | ||
| QT dispersion: time for an obituary? | Q50242821 | ||
| Mutational spectrum in the cardioauditory syndrome of Jervell and Lange-Nielsen. | Q50493312 | ||
| Task Force on Sudden Cardiac Death of the European Society of Cardiology. | Q52057914 | ||
| Prolongation of the QT interval and the sudden infant death syndrome. | Q52186927 | ||
| Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. | Q54095734 | ||
| Twenty single nucleotide polymorphisms (SNPs) and their allelic frequencies in four genes that are responsible for familial long QT syndrome in the Japanese population | Q57269490 | ||
| Guidelines for the interpretation of the neonatal electrocardiogram | Q58010911 | ||
| Electrocardiographic Prediction of Abnormal Genotype in Congenital Long QT Syndrome: Experience in 101 Related Family Members | Q58010947 | ||
| Sex differences in phenotypic manifestation and gene transmission in the Romano-Ward syndrome | Q58011347 | ||
| KCNQ1 gain-of-function mutation in familial atrial fibrillation | Q24338486 | ||
| Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 | Q28145423 | ||
| A novel long-QT 5 gene mutation in the C-terminus (V109I) is associated with a mild phenotype | Q28203626 | ||
| Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A) | Q28206505 | ||
| A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation | Q31119456 | ||
| Asthma and the risk of cardiac events in the Long QT syndrome. Long QT Syndrome Investigative Group | Q33145181 | ||
| Inherited long QT syndromes: a paradigm for understanding arrhythmogenesis | Q33145216 | ||
| Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. | Q33146000 | ||
| Bradycardia-induced long QT syndrome caused by a de novo missense mutation in the S2-S3 inner loop of HERG. | Q33146066 | ||
| Long QT syndrome in children: the value of the rate corrected QT interval in children who present with fainting | Q33147118 | ||
| Natural history of Brugada syndrome: insights for risk stratification and management | Q33147491 | ||
| Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia | Q33148058 | ||
| Risk stratification in the long-QT syndrome. | Q33148941 | ||
| Mutation analysis in congenital Long QT Syndrome--a case with missense mutations in KCNQ1 and SCN5A. | Q33149057 | ||
| Modulating effects of age and gender on the clinical course of long QT syndrome by genotype | Q33149140 | ||
| Short QT Syndrome: a familial cause of sudden death | Q33149259 | ||
| Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan | Q33151556 | ||
| Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs | Q33174249 | ||
| The long QT syndromes: genetic basis and clinical implications | Q33970623 | ||
| Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. | Q34325441 | ||
| Diagnostic criteria for the long QT syndrome. An update | Q34351752 | ||
| The implications of genetic mutations in the sodium channel gene (SCN5A). | Q35644037 | ||
| Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing | Q40428253 | ||
| Family and population strategies for screening and counselling of inherited cardiac arrhythmias | Q40506438 | ||
| Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes | Q40733443 | ||
| Identification of a genetic locus for familial atrial fibrillation | Q40900354 | ||
| In vivo human demonstration of phase 2 reentry | Q42418639 | ||
| The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome | Q43074306 | ||
| Evidence for a single nucleotide polymorphism in the KCNQ1 potassium channel that underlies susceptibility to life-threatening arrhythmias | Q43836448 | ||
| Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. | Q44323034 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | long QT syndrome | Q653924 |
| P304 | page(s) | 143-155 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Genetics in Medicine | Q15765508 |
| P1476 | title | The long QT syndrome family of cardiac ion channelopathies: a HuGE review | |
| P478 | volume | 8 |
| Q59200879 | A KCNQ1 V205M missense mutation causes a high rate of long QT syndrome in a First Nations community of northern British Columbia: a community-based approach to understanding the impact |
| Q26795687 | A Systematic Review on the Cost-Effectiveness of Genetic and Electrocardiogram Testing for Long QT Syndrome in Infants and Young Adults |
| Q33810586 | A novel genetic modifier for clarithromycin-related cardiac arrhythmia risk? |
| Q34540719 | Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel |
| Q58770371 | Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome |
| Q40635978 | Acute effects of ethanol on action potential and intracellular Ca(2+) transient in cardiac ventricular cells: a simulation study. |
| Q41033739 | An Isoform of Nedd4-2 Plays a Pivotal Role in Electrophysiological Cardiac Abnormalities. |
| Q46681639 | Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome |
| Q38846045 | Association between CACNA1C gene polymorphisms and ritodrine-induced adverse events in preterm labor patients |
| Q33565907 | Beyond the Electrocardiogram: Mutations in Cardiac Ion Channel Genes Underlie Nonarrhythmic Phenotypes |
| Q30426852 | Cardiac models in drug discovery and development: a review |
| Q37463403 | Cardiovascular translational medicine (IV): The genetic basis of malignant arrhythmias and cardiomyopathies. |
| Q35434773 | Channelopathies: summary of the hot topic keynotes session |
| Q57258989 | Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval |
| Q33153847 | Congenital long QT syndromes: clinical features, molecular genetics and genetic testing |
| Q27231482 | Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation |
| Q48277458 | Differential roles of two delayed rectifier potassium currents in regulation of ventricular action potential duration and arrhythmia susceptibility. |
| Q33949538 | Drug-induced QT interval prolongation: mechanisms and clinical management |
| Q36628028 | Dysfunctional potassium channel subunit interaction as a novel mechanism of long QT syndrome |
| Q37078819 | Family history: an essential tool for cardiovascular genetic medicine |
| Q33161629 | Genetic testing for long QT syndrome and the category of cardiac ion channelopathies |
| Q37766141 | Genetics of arrhythmia: disease pathways beyond ion channels |
| Q46129436 | Genomic-based diagnosis of arrhythmia disease in a personalized medicine era. |
| Q57001988 | Genotype and clinical characteristics of congenital long QT syndrome in Thailand |
| Q59335621 | Human Calmodulin Mutations |
| Q33155104 | Hypocalcaemia mimicking long QT syndrome: case report |
| Q24312557 | Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I |
| Q27332176 | Increased vulnerability of human ventricle to re-entrant excitation in hERG-linked variant 1 short QT syndrome |
| Q42359171 | International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointes |
| Q87782265 | LQTS parents' reflections about genetic risk knowledge and their need to know or not to know their children's carrier status |
| Q81814253 | Living with long QT syndrome: a qualitative study of coping with increased risk of sudden cardiac death |
| Q54358787 | Long QT syndrome mutation detection by SNaPshot technique. |
| Q34359106 | Mendelian-inherited heart disease: a gateway to understanding mechanisms in heart disease Update on work done at the University of Stellenbosch |
| Q37411148 | Modification by KCNE1 variants of the hERG potassium channel response to premature stimulation and to pharmacological inhibition |
| Q85075575 | Molecular determinants of hERG potassium channel inhibition by disopyramide |
| Q34463807 | Perceptions of an implantable cardioverter-defibrillator: A qualitative study of families with a history of sudden life-threatening cardiac events and recommendations to improve care. |
| Q36882194 | Phenotypic variability in Caucasian and Japanese patients with matched LQT1 mutations |
| Q36591586 | Post-transcriptional regulation of cardiac sodium channel gene SCN5A expression and function by miR-192-5p |
| Q36898747 | Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine |
| Q45945064 | Predicting the Functional Impact of KCNQ1 Variants of Unknown Significance. |
| Q82832886 | Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation |
| Q34100661 | Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation |
| Q36138280 | Primary hyperparathyroidism and its management in a woman with hereditary long QT syndrome |
| Q35065301 | Protein kinase A activity at the endoplasmic reticulum surface is responsible for augmentation of human ether-a-go-go-related gene product (HERG). |
| Q37684312 | Race and gender representation of hypertrophic cardiomyopathy or long QT syndrome cases in a South African research setting. |
| Q28306966 | Relationship between genetic variants in myocardial sodium and potassium channel genes and QT interval duration in diabetics: the Diabetes Heart Study |
| Q36832399 | Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation |
| Q37235823 | Review and management of the dental patient with Long QT syndrome (LQTS). |
| Q42021474 | Suppression of the hERG potassium channel response to premature stimulation by reduction in extracellular potassium concentration |
| Q92815378 | The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases |
| Q36952741 | The diagnosis and treatment of cardiac ion channelopathies: congenital long QT syndrome and Brugada syndrome |
| Q28262724 | The genetic basis of long QT and short QT syndromes: a mutation update |
| Q39503158 | The hERG K(+) channel S4 domain L532P mutation: characterization at 37°C |
| Q33865988 | The impact of patents on the development of genome-based clinical diagnostics: an analysis of case studies |
| Q37082703 | The new biology: a bridge to clinical cardiology |
| Q35661122 | The use of Bcl-2 over-expression to stabilize hybridomas specific to the HERG potassium channel |
| Q38110520 | miRNA in the regulation of ion channel/transporter expression |
Search more.